Cargando…
Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway
Podocyte lipid accumulation is a potential therapeutic target for diabetic nephropathy (DN). This study was aimed at clarifying the mechanism of Gandi capsule (GDC) ameliorating DN by regulating the lipid metabolism of podocytes. Network pharmacology methods were performed to screen the key molecule...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038418/ https://www.ncbi.nlm.nih.gov/pubmed/35480869 http://dx.doi.org/10.1155/2022/6275505 |
_version_ | 1784693916565504000 |
---|---|
author | Zhang, Ying Yao, Huijuan Li, Chao Sun, Wei Chen, Xiaofei Cao, Yan Liu, Yue Liu, Yan Chen, Jihui Qi, Jia Zhang, Qiqiang Zhang, Hai Xu, Ajing Zhang, Jian |
author_facet | Zhang, Ying Yao, Huijuan Li, Chao Sun, Wei Chen, Xiaofei Cao, Yan Liu, Yue Liu, Yan Chen, Jihui Qi, Jia Zhang, Qiqiang Zhang, Hai Xu, Ajing Zhang, Jian |
author_sort | Zhang, Ying |
collection | PubMed |
description | Podocyte lipid accumulation is a potential therapeutic target for diabetic nephropathy (DN). This study was aimed at clarifying the mechanism of Gandi capsule (GDC) ameliorating DN by regulating the lipid metabolism of podocytes. Network pharmacology methods were performed to screen the key molecules and potential targets of GDC for constructing the molecular-protein interaction network of GDC and conducting signal pathway enrichment analysis. GDC was predicted to ameliorate DN through SIRT1/AMPK/HNF4A pathway. Our results showed that GDC improved renal function in db/db mice. Besides, GDC exhibited effectiveness in relieving kidney tissue damage and renal lipid accumulation in db/db mice, and same effects were present in GDC-active ingredient baicalin. We further proved the new role of HNF4A in the lipid metabolism of DN mediated by SIRT1 and AMPK signaling pathways. The results suggested decreased expression of SIRT1 and p-AMPKα in the kidney tissue and increased expression of HNF4A of db/db mice compared with the control group. GDC and baicalin could reverse these expression changes. Furthermore, similar expression changes were observed in the murine podocyte cell line (MPC-5) treated with different concentrations of GDC and baicalin. Our research suggested that GDC and its active ingredient baicalin could alleviate the abnormal lipid metabolism in the kidney of db/db mice and might exert renal protection through the SIRT1/AMPK/HNF4A pathway. |
format | Online Article Text |
id | pubmed-9038418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-90384182022-04-26 Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway Zhang, Ying Yao, Huijuan Li, Chao Sun, Wei Chen, Xiaofei Cao, Yan Liu, Yue Liu, Yan Chen, Jihui Qi, Jia Zhang, Qiqiang Zhang, Hai Xu, Ajing Zhang, Jian Oxid Med Cell Longev Research Article Podocyte lipid accumulation is a potential therapeutic target for diabetic nephropathy (DN). This study was aimed at clarifying the mechanism of Gandi capsule (GDC) ameliorating DN by regulating the lipid metabolism of podocytes. Network pharmacology methods were performed to screen the key molecules and potential targets of GDC for constructing the molecular-protein interaction network of GDC and conducting signal pathway enrichment analysis. GDC was predicted to ameliorate DN through SIRT1/AMPK/HNF4A pathway. Our results showed that GDC improved renal function in db/db mice. Besides, GDC exhibited effectiveness in relieving kidney tissue damage and renal lipid accumulation in db/db mice, and same effects were present in GDC-active ingredient baicalin. We further proved the new role of HNF4A in the lipid metabolism of DN mediated by SIRT1 and AMPK signaling pathways. The results suggested decreased expression of SIRT1 and p-AMPKα in the kidney tissue and increased expression of HNF4A of db/db mice compared with the control group. GDC and baicalin could reverse these expression changes. Furthermore, similar expression changes were observed in the murine podocyte cell line (MPC-5) treated with different concentrations of GDC and baicalin. Our research suggested that GDC and its active ingredient baicalin could alleviate the abnormal lipid metabolism in the kidney of db/db mice and might exert renal protection through the SIRT1/AMPK/HNF4A pathway. Hindawi 2022-04-18 /pmc/articles/PMC9038418/ /pubmed/35480869 http://dx.doi.org/10.1155/2022/6275505 Text en Copyright © 2022 Ying Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhang, Ying Yao, Huijuan Li, Chao Sun, Wei Chen, Xiaofei Cao, Yan Liu, Yue Liu, Yan Chen, Jihui Qi, Jia Zhang, Qiqiang Zhang, Hai Xu, Ajing Zhang, Jian Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title | Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title_full | Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title_fullStr | Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title_full_unstemmed | Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title_short | Gandi Capsule Improved Podocyte Lipid Metabolism of Diabetic Nephropathy Mice through SIRT1/AMPK/HNF4A Pathway |
title_sort | gandi capsule improved podocyte lipid metabolism of diabetic nephropathy mice through sirt1/ampk/hnf4a pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038418/ https://www.ncbi.nlm.nih.gov/pubmed/35480869 http://dx.doi.org/10.1155/2022/6275505 |
work_keys_str_mv | AT zhangying gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT yaohuijuan gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT lichao gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT sunwei gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT chenxiaofei gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT caoyan gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT liuyue gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT liuyan gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT chenjihui gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT qijia gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT zhangqiqiang gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT zhanghai gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT xuajing gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway AT zhangjian gandicapsuleimprovedpodocytelipidmetabolismofdiabeticnephropathymicethroughsirt1ampkhnf4apathway |